The medical dictionary for regulatory activities (MedDRA).
about
Building a common pediatric research terminology for accelerating child health research.A systematic investigation of computation models for predicting Adverse Drug Reactions (ADRs)Adverse drug reaction prediction using scores produced by large-scale drug-protein target docking on high-performance computing machinesBias in spontaneous reporting of adverse drug reactions in JapanA Novel Drug-Mouse Phenotypic Similarity Method Detects Molecular Determinants of Drug EffectsNeuroRDF: semantic integration of highly curated data to prioritize biomarker candidates in Alzheimer's diseaseCommunity-based Ontology Development, Annotation and Discussion with MediaWiki extension Ontokiwi and Ontokiwi-based OntobediaLinking rare and common disease: mapping clinical disease-phenotypes to ontologies in therapeutic target validationThe RICORDO approach to semantic interoperability for biomedical data and models: strategy, standards and solutionsOrganization and representation of patient safety data: current status and issues around generalizability and scalabilityOntology-based collection, representation and analysis of drug-associated neuropathy adverse eventsSodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled TrialDictionary construction and identification of possible adverse drug events in Danish clinical narrative textSystematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease.Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS).Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease.Similarity-based prediction for Anatomical Therapeutic Chemical classification of drugs by integrating multiple data sources.Hepatotoxicity associated with agomelatine and other antidepressants: Disproportionality analysis using pooled pharmacovigilance data from the Uppsala Monitoring Centre.Application of data mining techniques in pharmacovigilance.GraphSAW: a web-based system for graphical analysis of drug interactions and side effects using pharmaceutical and molecular dataTrivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System Organ Classes Using VAERS Data.Drug-induced adverse events prediction with the LINCS L1000 dataSerious adverse drug events related to non-investigational drugs in academic clinical trials: another source of safety data for risk assessment?Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance database.Data standards in clinical research: gaps, overlaps, challenges and future directionsPopulation Analysis of Adverse Events in Different Age Groups Using Big Clinical Trials DataIdentification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data.A retrospective population-based study on seizures related to childhood vaccination.Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study.Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase®.Assisting the translation of SNOMED CT into French using UMLS and four representative French-language terminologies.Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study.Exploitation of semantic methods to cluster pharmacovigilance termsIntegrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitant.Predicting adverse drug reactions using publicly available PubChem BioAssay dataOAE: The Ontology of Adverse Events.Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIVTranslating the Foundational Model of Anatomy into French using knowledge-based and lexical methodsComputational methods for early predictive safety assessment from biological and chemical data.Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events.
P2860
Q26827600-2A5B06DC-E829-4963-8AA2-09EC13AF414FQ28542690-5B9698D9-EB6C-46CC-B531-C647866E4654Q28542829-51C91D8C-FBAB-4F35-B993-DF218A926A97Q28546900-110410DB-A962-44E2-96D7-4743B6666C5FQ28554371-22F1EB0D-45D9-4A55-8F66-DE1CBC60C370Q28596503-08F06EE5-F17E-4E93-AFD2-91CD4AC592FCQ28596944-7F64A38C-DA25-4B65-A5D0-474E5D0704ABQ28602105-B587AEA9-6A22-44BF-8EA5-6D558E600D13Q28743916-E333D257-1CAB-49B0-8F67-AD781351A53FQ28770108-168ACD1E-F9B7-4FDD-A061-7F66254B694FQ28833683-733F0210-33EC-4FEB-8197-C39C6174B71CQ28972231-66C31227-D5B9-4139-835F-C1037FE9E186Q30002316-24D5AC37-3E05-4A73-A78D-C37C52B3DBADQ30234628-627EB06F-B4E5-443E-A20A-79A630984490Q30375323-ABA385BB-45FB-49E6-A45F-0BB3F195E1A1Q30584275-BD3789DC-CE61-40DA-A72B-508AE76740DCQ30886870-D998BD37-1E48-4EE5-AD94-38553B57E2C6Q30887490-7592D7D7-62B3-43A7-9FDE-34F808BBA963Q30891302-A92E5528-3074-40FE-A7A8-9F62C1E06673Q30934294-B9D5E525-87C5-4396-8755-B43C594D1DCCQ30986593-E8AB4CAD-0E99-4EA8-8749-0DB35D1A13D8Q31092242-3774E983-73FC-4B07-9874-533A605FB696Q31106486-79EFB543-1DB1-4F77-88D0-839EFBAF1B6DQ31108809-38C9A9F7-B6BE-453E-98AE-B81CDB4179C1Q31122338-1BD86C58-1C18-4498-9943-8A7958F7327BQ31137297-698B95C4-9694-45A1-9B55-D4DAFDB01CF9Q31153431-8C05D850-7338-42CC-B925-3C1F9EF0C0E2Q33160174-F4BE1B92-18B9-4543-853B-79BB5C57B795Q33408915-1D24CBF1-2075-4C8A-9B67-A8A36F3B3F7CQ33425628-FB26768A-D0F3-49C2-97EB-5AA2C4BEBF41Q33626475-935CD607-09FC-45AE-8A4C-1CEEA18829D0Q33681951-2289D237-067F-4144-BA32-D4191BDB666EQ33715057-0C73F79D-A395-45BF-B36A-64A0C52E647FQ33749075-8C8982A4-FF37-4B11-80D5-8F24B7AEA62BQ33912477-AED81C30-7766-48EF-ACA6-B4BA041A5E49Q33997761-0A909783-D5FF-4367-9A55-1DEE8BD73880Q34036150-7B7711DE-4F12-4DFA-BC5E-9EEE45E52EA0Q34059071-77997684-83CD-4CAC-9C71-32F32DAEF9F2Q34066066-11BFFE0A-632A-42DC-BBFD-37B0259CCFB4Q34154208-C4F8289B-E567-47BE-9174-347345196180
P2860
The medical dictionary for regulatory activities (MedDRA).
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The medical dictionary for regulatory activities (MedDRA).
@ast
The medical dictionary for regulatory activities (MedDRA).
@en
The medical dictionary for regulatory activities
@nl
type
label
The medical dictionary for regulatory activities (MedDRA).
@ast
The medical dictionary for regulatory activities (MedDRA).
@en
The medical dictionary for regulatory activities
@nl
prefLabel
The medical dictionary for regulatory activities (MedDRA).
@ast
The medical dictionary for regulatory activities (MedDRA).
@en
The medical dictionary for regulatory activities
@nl
P2093
P1433
P1476
The medical dictionary for regulatory activities (MedDRA).
@en
P2093
P304
P356
10.2165/00002018-199920020-00002
P577
1999-02-01T00:00:00Z
P6179
1045853184